Moleculin Biotech, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Houston, TX
MBRX chart
What traders are saying about $MBRX
Latest postsMoleculin Biotech, Inc. news
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga ·
- Price to book ratio of Moleculin Biotech, Inc. – LS:A42P30
TradingView ·
- Moleculin Biotech (MBRX) Stock Price, News & Analysis
Stock Titan ·
- Moleculin Biotech, Inc. Estimates – NASDAQ:MBRX
TradingView ·
- Stock splits calendar for:
Yahoo Finance Australia ·
- Enterprise value to revenue forward of Moleculin Biotech, Inc. – MUN:MOL
TradingView ·
- Moleculin Releases Next CEO Corner Segment Highlighting Recent Progress in Annamycin MIRACLE Trial
Yahoo Finance ·
- Moleculin Announces Reverse Stock Split
Yahoo Finance ·
- Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit
Yahoo Finance ·
- Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
Yahoo Finance ·
- Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine
Yahoo Finance ·
- Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
Yahoo Finance ·
Moleculin Biotech, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net income | $33.6M | $26.0M | $29.8M | -$29.0M |
| Total assets (year end) | $22.1M | $16.9M | $38.2M | $57.4M |
| Cash and equivalents (year end) | $8.9M | $4.3M | $23.6M | $43.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Moleculin Biotech, Inc.
- Ticker
- MBRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Houston, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1659617
Frequently asked questions
What exchange is Moleculin Biotech, Inc. listed on?
Moleculin Biotech, Inc. trades on the Nasdaq under the ticker symbol MBRX.
What industry is Moleculin Biotech, Inc. in?
Moleculin Biotech, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Moleculin Biotech, Inc. headquartered?
Moleculin Biotech, Inc.'s business address on file with the SEC is in Houston, TX.
When does Moleculin Biotech, Inc.'s fiscal year end?
Moleculin Biotech, Inc.'s fiscal year ends on December 31.
How much revenue did Moleculin Biotech, Inc. report?
Moleculin Biotech, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.